Tomligisiran sodium
Tomligisiran sodium is an siRNA component of JNJ-3989. JNJ-3989 consists of two siRNAs, Daplusiran and Tomligisiran, which target and degrade the mRNA of the hepatitis B virus (HBV), thereby inhibiting the replication of HBV.
Product Specifications
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
